Nanovectors for Neurotherapeutic Delivery Part II: Polymeric Nanoparticles by M. Pitorre et al.
Nanovectors for Neurotherapeutic Delivery Part II:
Polymeric Nanoparticles
Submitted by Guillaume Bastiat on Mon, 04/27/2015 - 14:26










l'ouvrage Advances in Neurotherapeutic Delivery Technologies
Edition OMICS Group eBooks
Auteur Pitorre, Marion [1], Simonsson, Carl [2], Bastiat, Guillaume [3], Salomon, Claudio [4]
Editeur
scientifique Pillay, Viness [5], Choonara, Yahya E [6]
Pays Etats-Unis
Editeur OMICS Group eBooks
Ville Foster City
Mots-clés
Alzheimer’s disease [7], engineered polymeric nanoparticles [8], Glioblastoma [9],




Despite major advances in intracranial surgery and delivery of drugs to the brain,
treatment of neurological diseases remains one of the great medical challenges of our
days. The complexity of the organ makes surgical procedures complicated, and
conventional systemic delivery of drugs to the brain is hampered by low drug
selectivity and low drug partitioning over the blood-brain barrier. Due to the high
social and economic impacts related to diseases of the central nervous system,
development of new improved treatments of brain related disorders is of significant
value, both for the patient and for the society. Nanomedicine is a rapidly growing field
in the development of novel therapies for treatments of brain pathologies. The
scientific progress in nanotechnology has resulted in several new innovative nano-
assemblies, with promising medical potentials. Therapeutic benefits related to the use
of nanovectors includes, reduced chemical and enzymatic degradation of drugs,
increased uptake over biological barriers, improved selectivity by surface modification
using targeting ligands, and reduced toxic side effects in non-target tissue. This
review discusses various applications of polymeric nanoparticles as nanovectors in
treatment of neuronal diseases, specifically illustrated for Alzheimer’s and
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